cefoperazone has been researched along with Leukemia, Myeloid, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delmer, A; Helou, C; Marie, JP; Thevenin, D; Zittoun, R | 1 |
| Afanas'ev, BV; Shmidt, AV; Zabelina, TS; Zubarevskaia, LS | 1 |
| Kimura, I; Kitamura, K; Masaoka, T; Miyazaki, T; Mizoguchi, H; Niho, Y; Saito, H; Takaku, F | 1 |
1 trial(s) available for cefoperazone and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
[Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoperazone; Drug Compounding; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Sulbactam | 1991 |
2 other study(ies) available for cefoperazone and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
In vitro effect of P-glycoprotein (P-gp) modulators on drug sensitivity of leukemic progenitors (CFU-L) in acute myelogenous leukemia (AML).
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cefoperazone; Cyclosporine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Middle Aged; Mitoxantrone; Stem Cells; Tumor Cells, Cultured; Verapamil | 1992 |
[Experience with using cefoperazone in cancer patients after bone marrow transplantation].
Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Cefoperazone; Child; Child, Preschool; Female; Hodgkin Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Pancytopenia; Postoperative Care; Surgical Wound Infection | 1992 |